NCT00614198

Brief Summary

A growing body of research indicates that dietary intervention excluding foods containing the proteins, gluten and casein, from the diet of children diagnosed with an autism spectrum disorder (ASD) may have a positive effect on behaviour and developmental outcome. In this single-blind, randomised-controlled, matched-pair adaptive trial, we introduced a gluten- and casein-free (GFCF) diet to a group of pre-pubescent children diagnosed with ASD concurrently with an abnormal urinary profile. Following random allocation to a diet or non- diet group, stage 1 of the study saw an intervention group follow the GFCF diet for eight months initially - progressing to 12 months if required. A non-diet control group continued with a normal diet. Assuming significant changes for the dietary group on the various outcome measures of behaviour and development, stage 2 of the study saw both groups assigned to GFCF dietary intervention for a further 12 months when outcome measures were again assessed at study end.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Apr 2006

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2006

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 13, 2008

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2008

Completed
2 years until next milestone

Results Posted

Study results publicly available

October 1, 2010

Completed
Last Updated

October 1, 2010

Status Verified

May 1, 2010

Enrollment Period

2.5 years

First QC Date

January 31, 2008

Results QC Date

May 17, 2010

Last Update Submit

August 31, 2010

Conditions

Keywords

autismautism spectrum disorderdietglutencaseininterventionpeptiderandomisedcontrolledadaptive designAutism Diagnostic Observation Schedule (ADOS)Gilliam Autism Rating Scale (GARS)Vineland Adaptive Behaviour Scale (VABS)Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale

Outcome Measures

Primary Outcomes (1)

  • Change in Diet Groups Scores on One of Several Measures Used Against Pre-defined Statistical Thresholds as Evidence of Improvement.

    ADOS (Autism Diagnostic Observation Schedule): module 1 cutoff scores (communication+social): autism=12, autism spectrum (AS)=7; module 2 cutoffs: autism=12, AS=8; module 3 cutoffs: autism=10; AS=7. GARS (Gilliam Autism Rating Scale): \<80 low probability of autism, 81-90 below average, 91-110 average, \>110 above average probability of autism. VABS (Vineland Adaptive Behaviour Scale): \<69 (low ability), 70-84 (moderate/low), 85-115 (adequate), 116-130 (moderate/high), \>130 (high). ADHD-IV: 0=no problems indicated. \>11 attention \& \>11 hyperactivity = ADHD diagnosis.

    Baseline - 8 months - 12 months - 24 months

Secondary Outcomes (1)

  • Changes to Appearance of Multiple Compounds in Urine Samples

    Baseline - 8 months -12 months - 24 months

Study Arms (2)

Gluten- and casein-free diet

EXPERIMENTAL

Stage 1: Gluten- and casein-free dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If showed group significant improvements then progressed to stage 2 (continued on a gluten- and casein-free diet for a further 12 months).

Other: Gluten- and casein-free diet

No dietary intervention

NO INTERVENTION

Stage 1: No special dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If gluten- and casein-free dietary group showed group significant improvements then progressed to stage 2 (introduction of a gluten- and casein-free diet for 12 months).

Interventions

Removal of foods containing gluten (cereal produce) and casein (dairy produce)

Also known as: Gluten-free (wheat-free), casein- free (milk-free) diets
Gluten- and casein-free diet

Eligibility Criteria

Age4 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Autism Spectrum Disorder (ASD)
  • Diagnosis received at Centre for Autism or a psychiatric clinic
  • Abnormal urinary peptide profile

You may not qualify if:

  • Medical treatment
  • Epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Whiteley P, Haracopos D, Knivsberg AM, Reichelt KL, Parlar S, Jacobsen J, Seim A, Pedersen L, Schondel M, Shattock P. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci. 2010 Apr;13(2):87-100. doi: 10.1179/147683010X12611460763922.

Related Links

MeSH Terms

Conditions

Autistic DisorderAutism Spectrum DisorderAttention Deficit Disorder with Hyperactivity

Interventions

GlutensDiet, Gluten-FreeDiet

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersAttention Deficit and Disruptive Behavior Disorders

Intervention Hierarchy (Ancestors)

ProlaminsGrain ProteinsPlant ProteinsProteinsAmino Acids, Peptides, and ProteinsSeed Storage ProteinsDiet TherapyNutrition TherapyTherapeuticsNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Limitations and Caveats

Single-blind trial, no placebo condition, analysis based on per protocol (not intention to treat), socio-economic status not recorded, independent screening for underlying somatic conditions potentially associated with results not undertaken

Results Point of Contact

Title
Lennart Pedersen
Organization
Center for Autisme

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 31, 2008

First Posted

February 13, 2008

Study Start

April 1, 2006

Primary Completion

October 1, 2008

Study Completion

October 1, 2008

Last Updated

October 1, 2010

Results First Posted

October 1, 2010

Record last verified: 2010-05